Development of Liposomal Combination Therapy to Target Cancer Stem Cells in Trastuzumab-Resistant HER2 Positive Breast Cancer

Files in this item

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics